洪明奇 臺灣分子生物學家
Hung, Mien-chie
هونغ، مين تشي
VIAF ID: 74174703 (Personal)
Permalink: http://viaf.org/viaf/74174703
Preferred Forms
- 200 _ | ‡a Hung ‡b Mien-Chie
- 100 1 _ ‡a Hung, Mien-Chie
- 100 1 _ ‡a Hung, Mien-Chie
-
-
-
- 100 1 _ ‡a Hung, Mien-chie
-
-
- 100 0 _ ‡a 洪明奇 ‡c 臺灣分子生物學家
4xx's: Alternate Name Forms (9)
Works
Title | Sources |
---|---|
Breast Cancer and Molecular Medicine | |
Breast cancer chemosensitivity | |
Different restriction enzyme-generated sticky DNA ends can be joined in vitro | |
Expression of PEA3 and lack of correlation between PEA3 and HER-2/neu expression in breast cancer | |
Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway | |
EZH2: a pivotal regulator in controlling cell differentiation. | |
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. | |
EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling | |
EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling | |
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells | |
A flow-proteometric platform for analyzing protein concentration (FAP): Proof of concept for quantification of PD-L1 protein in cells and tissues | |
FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer | |
FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization | |
Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology | |
Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells. | |
Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues | |
Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation | |
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy | |
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. | |
GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. | |
H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism | |
Hepatitis B virus X protein induces IKKα nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells | |
Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma | |
HER-2/neu Oncogene Characterization in Head and Neck Squamous Cell Carcinoma | |
HER-2/Neu signaling and therapeutic approaches in breast cancer. | |
HER-2/neu-targeting gene therapy-a review | |
HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer | |
HER2/neu in the management of invasive breast cancer | |
Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells | |
HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis. | |
High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients | |
High speed digital protein interaction analysis using microfluidic single molecule detection system | |
Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties | |
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation | |
IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a | |
IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. | |
IKKα activation of NOTCH links tumorigenesis via FOXA2 suppression | |
Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform | |
Induction of Akt activity by chemotherapy confers acquired resistance | |
Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases | |
Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killing | |
Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma | |
Inhibition of cancer cell growth by BRCA2. | |
Inhibition of CDK2 reduces EZH2 phosphorylation and reactivates ERα expression in high-grade serous ovarian carcinoma | |
Inhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasis | |
Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis | |
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer | |
Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer | |
Interferon-inducible protein IFIXalpha inhibits cell invasion by upregulating the metastasis suppressor maspin | |
Intracaecal Orthotopic Colorectal Cancer Xenograft Mouse Model | |
JNK1 negatively controls antifungal innate immunity by suppressing CD23 expression | |
Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression. | |
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. | |
KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta | |
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. | |
Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion | |
Lapatinib-mediated cyclooxygenase-2 expression via epidermal growth factor receptor/HuR interaction enhances the aggressiveness of triple-negative breast cancer cells | |
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker | |
Linear ubiquitination of cFLIP induced by LUBAC contributes to TNFa-induced apoptosis | |
lncRNA directs cooperative epigenetic regulation downstream of chemokine signals | |
LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition | |
Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. | |
Long noncoding RNA MALAT1 suppresses breast cancer metastasis | |
Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. | |
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers | |
Lymphotoxin-β Interacts with Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer. | |
MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer | |
MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation | |
MEASUREMENT of Protein 53 Diffusion Coefficient in Live HeLa Cells Using Raster Image Correlation Spectroscopy (RICS). | |
Mechanisms Controlling PD-L1 Expression in Cancer | |
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer | |
Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death | |
Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2. | |
MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1 | |
Metastasis regulation by PPARD expression in cancer cells. | |
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer | |
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1 | |
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer. | |
A new fork for clinical application: targeting forkhead transcription factors in cancer | |
Non-viral vectors for gene therapy. | |
A novel hTERT promoter-driven E1A therapeutic for ovarian cancer. | |
A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases | |
A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer | |
A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma |